Global Chance Fund

Company

Investment-firm

Financing round

General

About Company
Global Chance Fund is a venture capital firm that primarily invests in the healthcare sector.

Industry

Sector :

Subsector :

founded date

01.01.2003

IPO status

Private

Description

Established in Germany in 2003, Global Chance Fund has a main office in Landshut and typically invests between $10 million and $50 million in deals. The fund is active in less than two deals per year, with its peak activity in 2004. It often invests in rounds with three participants and is frequently joined by sponsors such as S-Refit, MIG AG, and Global Asset Fund. The fund has a preference for investing in startups located in Germany and in the 6-10 year age range. Notable portfolio companies include Isarna Therapeutics.
Similar Companies
1000
3E Bioventures

3E Bioventures

3E Bioventures Capital is a healthcare-focused venture investment fund that manages both RMB and US Dollar funds.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Beijing, China

count Of Investments

50

count Of Exists

1
Vivo Capital

Vivo Capital

Vivo Capital is a global investment firm focused on healthcare, with approximately $5.8 billion in assets under management.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Health Care, Venture Capital

Location

Palo Alto, CA, USA

count Of Investments

187

count Of Exists

30
OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

561

count Of Exists

82
CW Ventures

CW Ventures

CW Group is a leading manager of medical venture capital funds focused on seed and early stage healthcare investing.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Financial Services, Health Care

Location

New York, NY, USA

count Of Investments

8

count Of Exists

3

Financials

Investments
2
Date 
name 
Lead 
type 
Raised 
30.04.2004
No
$11.98M
Local Amount - EUR 10M
Isarna Therapeutics

Isarna Therapeutics

Isarna Therapeutics is a biotech company committed to developing selective TGF-β inhibitors to treat ophthalmic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Munich, Germany

total rounds

7

total raised

$124.22M
Isarna Therapeutics

Isarna Therapeutics

Isarna Therapeutics is a biotech company committed to developing selective TGF-β inhibitors to treat ophthalmic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Munich, Germany

total rounds

7

total raised

$124.22M
Co-Investors

Activity

Recent News
0